Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 31 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2017 Filed Aug 17, 2017 21:33 UTC |
MORRISON PATRICIAChief Information Officer
|
GrantCommon Shares | 6,021 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000096 · wf-form4_150300559238942.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,551 F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2018. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:31 UTC |
Kimmet Pamela OChief Human Resources Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 29,517 | $0.00 Strike: $66.43 | $0.00 |
DisclosureSEC source: 0000721371-17-000094 · wf-form4_150300547534740.xml · derivative · entry 3 Kimmet Pamela O. · CIK 0001589981 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,517 Underlying: Common Shares · 29,517 shares Expires 2027-08-15 F4 · derivative.exercise_date: Stock option vests in three equal annual installments beginning on August 15, 2018. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:31 UTC |
Kimmet Pamela OChief Human Resources Officer
|
Tax withholdingCommon Shares | 527 | $66.76 | $35,182.52 |
DisclosureSEC source: 0000721371-17-000094 · wf-form4_150300547534740.xml · nonDerivative · entry 2 Kimmet Pamela O. · CIK 0001589981 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,726 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 1,602 RSUs. F3 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:31 UTC |
Kimmet Pamela OChief Human Resources Officer
|
GrantCommon Shares | 6,021 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000094 · wf-form4_150300547534740.xml · nonDerivative · entry 1 Kimmet Pamela O. · CIK 0001589981 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,253 F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2018. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:27 UTC |
Holcomb MicheleEVP - Strategy & Corp. Dev.
|
GrantEmployee Stock Option (right to buy) · Derivative | 20,908 | $0.00 Strike: $66.43 | $0.00 |
DisclosureSEC source: 0000721371-17-000092 · wf-form4_150300524976431.xml · derivative · entry 2 Holcomb Michele · CIK 0001694167 · EVP - Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,908 Underlying: Common Shares · 20,908 shares Expires 2027-08-15 F2 · derivative.exercise_date: Stock option vests in three equal annual installments beginning on August 15, 2018. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:27 UTC |
Holcomb MicheleEVP - Strategy & Corp. Dev.
|
GrantCommon Shares | 4,265 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000092 · wf-form4_150300524976431.xml · nonDerivative · entry 1 Holcomb Michele · CIK 0001694167 · EVP - Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,932 F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2018. Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 20:34 UTC |
Casey Donald M Jr.CEO, Medical Segment
|
GrantCommon Shares | 13,034 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000076 · wf-form4_150231082741132.xml · nonDerivative · entry 1 Casey Donald M Jr. · CIK 0001423197 · CEO, Medical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,235 F1 · kind: Reflects performance share units that will settle on August 15, 2017. Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 20:31 UTC |
Morford Craig SChief Legal/Compliance Officer
|
GrantCommon Shares | 7,448 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000074 · wf-form4_150231069591081.xml · nonDerivative · entry 1 Morford Craig S · CIK 0001434592 · Chief Legal/Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,563 F1 · kind: Reflects performance share units that will settle on August 15, 2017. Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 20:29 UTC |
Barrett George SDirector · Chairman and CEO
|
GrantCommon Shares | 49,653 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000072 · wf-form4_150231055724670.xml · nonDerivative · entry 1 Barrett George S · CIK 0001425512 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 513,884 F1 · kind: Reflects performance share units that will settle on August 15, 2017. Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 20:26 UTC |
MORRISON PATRICIAChief Information Officer
|
GrantCommon Shares | 6,827 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000070 · wf-form4_150231039816895.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,530 F1 · kind: Reflects performance share units that will settle on August 15, 2017. Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 20:21 UTC |
LAWS STUART GSVP & Chief Accounting Officer
|
GrantCommon Shares | 1,552 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000066 · wf-form4_150231009368248.xml · nonDerivative · entry 1 LAWS STUART G · CIK 0001404127 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,160 F1 · kind: Reflects performance share units that will settle on August 15, 2017. Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 20:23 UTC |
Giacomin Jon LCEO, Pharmaceutical Segment
|
GrantCommon Shares | 10,976 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000068 · wf-form4_150231022236886.xml · nonDerivative · entry 1 Giacomin Jon L · CIK 0001623254 · CEO, Pharmaceutical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,146 F1 · kind: Reflects performance share units that will settle on August 15, 2017. Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 20:19 UTC | GrantCommon Shares | 13,034 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000064 · wf-form4_150230995425520.xml · nonDerivative · entry 2 Kaufmann Michael C · CIK 0001471294 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,132 F1 · kind: Reflects performance share units that will settle on August 15, 2017 Read SEC document |
|
| July 17, 2017 Filed Jul 17, 2017 20:58 UTC |
ANDERSON DAVID JDirector
|
GrantPhantom Stock · Derivative | 32 | $78.11 | $2,499.52 |
DisclosureSEC source: 0000721371-17-000050 · wf-form4_150032512182444.xml · derivative · entry 1 ANDERSON DAVID J · CIK 0001101124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62 Underlying: Common Shares · 32 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Price is closing price on July 14, 2017. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| July 17, 2017 Filed Jul 17, 2017 20:56 UTC |
DARDEN CALVINDirector
|
GrantPhantom Stock · Derivative | 64 | $78.11 | $4,999.04 |
DisclosureSEC source: 0000721371-17-000048 · wf-form4_150032499974273.xml · derivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,597 Underlying: Common Shares · 64 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Price is closing share price on July 14, 2017. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 20:10 UTC |
Kimmet Pamela OChief Human Resources Officer
|
Tax withholdingCommon Shares | 422 | $78.25 | $33,021.50 |
DisclosureSEC source: 0000721371-17-000046 · wf-form4_149928540101199.xml · nonDerivative · entry 1 Kimmet Pamela O. · CIK 0001589981 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,232 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 1,282 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| May 12, 2017 Filed May 15, 2017 20:59 UTC |
Giacomin Jon LCEO, Pharmaceutical Segment
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 23,270 | $41.60 Strike: $41.60 | $968,032.00 |
DisclosureSEC source: 0000721371-17-000035 · wf-form4_149488191986209.xml · derivative · entry 3 Giacomin Jon L · CIK 0001623254 · CEO, Pharmaceutical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 23,270 shares Expires 2021-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing a right to purchase a total of 23,270 shares, vested and became exercisable in three equal annual installments beginning on August 15, 2012. Read SEC document |
| May 12, 2017 Filed May 15, 2017 20:59 UTC |
Giacomin Jon LCEO, Pharmaceutical Segment
|
SaleCommon Shares | 23,270 | $72.87 | $1,695,684.90 |
DisclosureSEC source: 0000721371-17-000035 · wf-form4_149488191986209.xml · nonDerivative · entry 2 Giacomin Jon L · CIK 0001623254 · CEO, Pharmaceutical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,170 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.81 to $72.91, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4. Read SEC document |
| May 12, 2017 Filed May 15, 2017 20:59 UTC |
Giacomin Jon LCEO, Pharmaceutical Segment
|
Exercise / conversionCommon Shares | 23,270 | $41.60 | $968,032.00 |
DisclosureSEC source: 0000721371-17-000035 · wf-form4_149488191986209.xml · nonDerivative · entry 1 Giacomin Jon L · CIK 0001623254 · CEO, Pharmaceutical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,440 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2017 Filed May 9, 2017 21:38 UTC |
JONES CLAYTON MDirector
|
Disposition to issuerCommon Shares | 502 | $71.99 | $36,138.98 |
DisclosureSEC source: 0000721371-17-000033 · wf-form4_149436587228003.xml · nonDerivative · entry 1 JONES CLAYTON M · CIK 0001191566 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Clayton M. Jones Revocable Trust Disclosed balance after: 0 F1 · ownership.nature: These shares were held in a trust administered by a third party trustee. Read SEC document |
| May 08, 2017 Filed Nov 16, 2017 21:13 UTC Amendment |
JONES CLAYTON MDirector
|
SaleCommon Shares | 502 | $71.99 | $36,138.98 |
DisclosureSEC source: 0000721371-17-000171 · wf-form4a_151086681822959.xml · nonDerivative · entry 1 JONES CLAYTON M · CIK 0001191566 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Clayton M. Jones Revocable Trust Disclosed balance after: 0 F1 · kind: This amendment to Form 4 is filed solely to reflect that the correct Transaction Code for the reported transaction is "S". Read SEC document |
| April 17, 2017 Filed Apr 17, 2017 20:34 UTC |
DARDEN CALVINDirector
|
GrantPhantom Stock · Derivative | 61 | $81.43 | $4,967.23 |
DisclosureSEC source: 0000721371-17-000026 · wf-form4_149246125378170.xml · derivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,526 Underlying: Common Shares · 61 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Price is closing share price on April 13, 2017. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| April 17, 2017 Filed Apr 17, 2017 20:33 UTC |
ANDERSON DAVID JDirector
|
GrantPhantom Stock · Derivative | 30 | $81.43 | $2,442.90 |
DisclosureSEC source: 0000721371-17-000025 · wf-form4_149246118222797.xml · derivative · entry 1 ANDERSON DAVID J · CIK 0001101124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30 Underlying: Common Shares · 30 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Price is closing share price on April 13, 2017. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:59 UTC |
Barrett George SDirector · Chairman and CEO
|
Exercise / conversionCommon Shares · Derivative | 217,994 | $0.00 Strike: $30.94 | $0.00 |
DisclosureSEC source: 0000721371-17-000019 · wf-form4_148702314021294.xml · derivative · entry 3 Barrett George S · CIK 0001425512 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 217,994 shares Expires 2017-08-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing a right to purchase a total of 685,989 shares, vested and became exercisable in three equal annual installments beginning on August 16, 2011. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:59 UTC |
Barrett George SDirector · Chairman and CEO
|
SaleCommon Shares | 217,994 | $77.23 | $16,835,676.62 |
DisclosureSEC source: 0000721371-17-000019 · wf-form4_148702314021294.xml · nonDerivative · entry 2 Barrett George S · CIK 0001425512 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464,231 F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on August 8, 2016. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.79 to $77.66, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 21:59 UTC |
Barrett George SDirector · Chairman and CEO
|
Exercise / conversionCommon Shares | 217,994 | $30.94 | $6,744,734.36 |
DisclosureSEC source: 0000721371-17-000019 · wf-form4_148702314021294.xml · nonDerivative · entry 1 Barrett George S · CIK 0001425512 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 682,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sale reported on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on August 8, 2016. Read SEC document |
| January 16, 2017 Filed Jan 17, 2017 21:21 UTC |
DARDEN CALVINDirector
|
GrantPhantom Stock · Derivative | 66 | $75.00 | $4,950.00 |
DisclosureSEC source: 0000721371-17-000006 · wf-form4_148468806010756.xml · derivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,470 Underlying: Common Shares · 66 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Price is closing share price on January 13, 2017. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| January 16, 2017 Filed Jan 17, 2017 21:20 UTC |
Holcomb MicheleEVP - Strategy & Corp. Dev.
|
GrantCommon Shares | 8,667 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000005 · wf-form4_148468804341968.xml · nonDerivative · entry 1 Holcomb Michele · CIK 0001694167 · EVP - Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,667 F1 · kind: Grant of restricted share units that vest in three equal annual installments beginning on January 16, 2018. Read SEC document |
| November 30, 2016 Filed Aug 9, 2017 20:19 UTC | GiftCommon Shares | 3,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000064 · wf-form4_150230995425520.xml · nonDerivative · entry 1 Kaufmann Michael C · CIK 0001471294 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,098 Read SEC document |
|
| November 10, 2016 Filed Nov 14, 2016 13:25 UTC |
Barrett George SDirector · Chairman and CEO
|
Exercise / conversionCommon Shares · Derivative | 217,995 | $0.00 Strike: $30.94 | $0.00 |
DisclosureSEC source: 0000721371-16-000359 · wf-form4_147912990277850.xml · derivative · entry 5 Barrett George S · CIK 0001425512 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,994 Underlying: Common Shares · 217,995 shares Expires 2017-08-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing a right to purchase a total of 685,989 shares, vested and became exercisable in three equal annual installments beginning on August 16, 2011. Read SEC document |
| November 10, 2016 Filed Nov 14, 2016 13:25 UTC |
Barrett George SDirector · Chairman and CEO
|
SaleCommon Shares | 6,600 | $71.82 | $474,012.00 |
DisclosureSEC source: 0000721371-16-000359 · wf-form4_147912990277850.xml · nonDerivative · entry 4 Barrett George S · CIK 0001425512 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464,231 F1 · kind: The exercise and sales reported on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on August 8, 2016. F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.76 to $71.93, inclusive. Read SEC document |
| November 10, 2016 Filed Nov 14, 2016 13:25 UTC |
Barrett George SDirector · Chairman and CEO
|
SaleCommon Shares | 194,441 | $71.35 | $13,873,365.35 |
DisclosureSEC source: 0000721371-16-000359 · wf-form4_147912990277850.xml · nonDerivative · entry 3 Barrett George S · CIK 0001425512 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 470,831 F1 · kind: The exercise and sales reported on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on August 8, 2016. F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.76 to $71.75, inclusive. Read SEC document |
| November 10, 2016 Filed Nov 14, 2016 13:25 UTC |
Barrett George SDirector · Chairman and CEO
|
SaleCommon Shares | 16,954 | $70.40 | $1,193,561.60 |
DisclosureSEC source: 0000721371-16-000359 · wf-form4_147912990277850.xml · nonDerivative · entry 2 Barrett George S · CIK 0001425512 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 665,272 F1 · kind: The exercise and sales reported on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on August 8, 2016. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.76 to $70.75, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2 through 4 to this Form 4. Read SEC document |
| November 10, 2016 Filed Nov 14, 2016 13:25 UTC |
Barrett George SDirector · Chairman and CEO
|
Exercise / conversionCommon Shares | 217,995 | $30.94 | $6,744,765.30 |
DisclosureSEC source: 0000721371-16-000359 · wf-form4_147912990277850.xml · nonDerivative · entry 1 Barrett George S · CIK 0001425512 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 682,226 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sales reported on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on August 8, 2016. Read SEC document |
| November 03, 2016 Filed Nov 7, 2016 13:21 UTC |
DOWNEY BRUCEDirector
|
GrantCommon Shares | 2,447 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-16-000347 · wf-form4_147852486150264.xml · nonDerivative · entry 1 DOWNEY BRUCE · CIK 0001237257 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,362 F1 · shares: Grant of restricted share units that will vest on November 3, 2017, except if the 2017 Annual Meeting of Shareholders is prior to November 3, 2017, then the restricted share units will vest on the date of the 2017 Annual Meeting of Shareholders. Read SEC document |
| November 03, 2016 Filed Nov 7, 2016 13:22 UTC |
Killefer NancyDirector
|
GrantCommon Shares | 2,447 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-16-000351 · wf-form4_147852493907636.xml · nonDerivative · entry 1 Killefer Nancy · CIK 0001584637 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,295 F1 · shares: Grant of restricted share units that will vest on November 3, 2017, except if the 2017 Annual Meeting of Shareholders is prior to November 3, 2017, then the restricted share units will vest on the date of the 2017 Annual Meeting of Shareholders. Read SEC document |
| November 03, 2016 Filed Nov 7, 2016 13:22 UTC |
Arnold Colleen F.Director
|
GrantCommon Shares | 2,447 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-16-000350 · wf-form4_147852492163664.xml · nonDerivative · entry 1 Arnold Colleen F. · CIK 0001409123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,892 F1 · shares: Grant of restricted share units that will vest on November 3, 2017, except if the 2017 Annual Meeting of Shareholders is prior to November 3, 2017, then the restricted share units will vest on the date of the 2017 Annual Meeting of Shareholders. Read SEC document |
| November 03, 2016 Filed Nov 7, 2016 21:17 UTC |
KENNY GREGORY BDirector
|
GrantCommon Shares | 2,753 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-16-000357 · wf-form4_147855341755926.xml · nonDerivative · entry 1 KENNY GREGORY B · CIK 0001179497 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,697 F1 · shares: Grant of restricted share units that will vest on November 3, 2017, except if the 2017 Annual Meeting of Shareholders is prior to November 3, 2017, then the restricted share units will vest on the date of the 2017 Annual Meeting of Shareholders. Read SEC document |
| November 03, 2016 Filed Nov 7, 2016 13:21 UTC |
COX CARRIE SMITHDirector
|
GrantCommon Shares | 2,447 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-16-000349 · wf-form4_147852490113792.xml · nonDerivative · entry 1 COX CARRIE SMITH · CIK 0001110753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,064 F1 · shares: Grant of restricted share units that will vest on November 3, 2017, except if the 2017 Annual Meeting of Shareholders is prior to November 3, 2017, then the restricted share units will vest on the date of the 2017 Annual Meeting of Shareholders. Read SEC document |
| November 03, 2016 Filed Nov 7, 2016 13:20 UTC |
DARDEN CALVINDirector
|
GrantCommon Shares | 2,447 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-16-000346 · wf-form4_147852483802531.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,066 F1 · shares: Grant of restricted share units that will vest on November 3, 2017, except if the 2017 Annual Meeting of Shareholders is prior to November 3, 2017, then the restricted share units will vest on the date of the 2017 Annual Meeting of Shareholders. Read SEC document |
| November 03, 2016 Filed Nov 7, 2016 13:20 UTC |
JONES CLAYTON MDirector
|
GrantCommon Shares | 2,447 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-16-000345 · wf-form4_147852482114732.xml · nonDerivative · entry 1 JONES CLAYTON M · CIK 0001191566 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,341 F1 · shares: Grant of restricted share units that will vest on November 3, 2017, except if the 2017 Annual Meeting of Shareholders is prior to November 3, 2017, then the restricted share units will vest on the date of the 2017 Annual Meeting of Shareholders. Read SEC document |
| November 03, 2016 Filed Nov 7, 2016 13:20 UTC |
KING DAVID PDirector
|
GrantCommon Shares | 2,447 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-16-000344 · wf-form4_147852480593241.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,421 F1 · shares: Grant of restricted share units that will vest on November 3, 2017, except if the 2017 Annual Meeting of Shareholders is prior to November 3, 2017, then the restricted share units will vest on the date of the 2017 Annual Meeting of Shareholders. Read SEC document |
| November 03, 2016 Filed Nov 7, 2016 13:19 UTC |
ANDERSON DAVID JDirector
|
GrantCommon Shares | 2,447 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-16-000343 · wf-form4_147852478524936.xml · nonDerivative · entry 1 ANDERSON DAVID J · CIK 0001101124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,323 F1 · shares: Grant of restricted share units that will vest on November 3, 2017, except if the 2017 Annual Meeting of Shareholders is prior to November 3, 2017, then the restricted share units will vest on the date of the 2017 Annual Meeting of Shareholders. Read SEC document |
| November 03, 2016 Filed Nov 7, 2016 13:19 UTC |
Hall Patricia HemingwayDirector
|
GrantCommon Shares | 2,447 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-16-000342 · wf-form4_147852476426108.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,935 F1 · shares: Grant of restricted share units that will vest on November 3, 2017, except if the 2017 Annual Meeting of Shareholders is prior to November 3, 2017, then the restricted share units will vest on the date of the 2017 Annual Meeting of Shareholders. Read SEC document |
| October 17, 2016 Filed Oct 18, 2016 12:38 UTC |
DARDEN CALVINDirector
|
GrantPhantom Stock · Derivative | 66 | $75.27 | $4,967.82 |
DisclosureSEC source: 0000721371-16-000317 · wf-form4_147679429082138.xml · derivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,404 Underlying: Common Shares · 66 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Price is closing share price on October 14, 2016. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 12:26 UTC | Tax withholdingCommon Shares | 6,330 | $75.26 | $476,395.80 |
DisclosureSEC source: 0000721371-16-000315 · wf-form4_147428794995096.xml · nonDerivative · entry 1 Kaufmann Michael C · CIK 0001471294 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,598 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 13,340 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
|
| September 15, 2016 Filed Sep 19, 2016 12:25 UTC |
Giacomin Jon LCEO, Pharmaceutical Segment
|
Tax withholdingCommon Shares | 845 | $75.26 | $63,594.70 |
DisclosureSEC source: 0000721371-16-000314 · wf-form4_147428793264130.xml · nonDerivative · entry 1 Giacomin Jon L · CIK 0001623254 · CEO, Pharmaceutical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,170 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 1,779 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 12:25 UTC |
Casey Donald M Jr.CEO, Medical Segment
|
Tax withholdingCommon Shares | 4,748 | $75.26 | $357,334.48 |
DisclosureSEC source: 0000721371-16-000313 · wf-form4_147428791486172.xml · nonDerivative · entry 1 Casey Donald M Jr. · CIK 0001423197 · CEO, Medical Segment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,201 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 10,005 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 12:25 UTC |
LAWS STUART GSVP & Chief Accounting Officer
|
Tax withholdingCommon Shares | 110 | $75.26 | $8,278.60 |
DisclosureSEC source: 0000721371-16-000312 · wf-form4_147428789934972.xml · nonDerivative · entry 1 LAWS STUART G · CIK 0001404127 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,608 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 333 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.